Antimetastatic defense by CD8+ T cells

Autor: Tallón de Lara, Paulino ^{1, 2, ⁎, @}, Castañón, Héctor ^{3, 4}, Sterpi, Michelle ^{1, 2}, van den Broek, Maries ^{3, 4}

Publikováno v: In Trends in Cancer February 2022 8(2):145-157

CD39+PD-1+CD8+ T cells mediate metastatic dormancy in breast cancer.

Autor: Tallón de Lara, Paulino, Castañón, Héctor, Vermeer, Marijne, Núñez, Nicolás, Silina, Karina, Sobottka, Bettina, Urdinez, Joaquín, Cecconi, Virginia, Yagita, Hideo, Movahedian Attar, Farkhondeh, Hiltbrunner, Stefanie, Glarner, Isabelle, Moch, Holger, Tugues, Sònia, Becher, Burkhard, van den Broek, Maries

Publikováno v: Nature Communications; 2/3/2021, Vol. 12 Issue 1, p1-14, 14p

Antimetastatic defense by CD8+T cells

Autor: Tallón de Lara, Paulino, Castañón, Héctor, Sterpi, Michelle, van den Broek, Maries

Publikováno v: Trends in Cancer; 20210101, Issue: Preprints

CD39 ⁺ PD-1 ⁺ CD8 ⁺ T cells mediate metastatic dormancy in breast cancer.

Autor: Tallón de Lara P; Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland.; Comprehensive Cancer Center Zurich, Zurich, Switzerland.; Department of Medicine, Mount Sinai St. Luke's & Mount Sinai West, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Castañón H; Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland.; Comprehensive Cancer Center Zurich, Zurich, Switzerland., Vermeer M; Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland.; Comprehensive Cancer Center Zurich, Zurich, Switzerland., Núñez N; Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland.; Comprehensive Cancer Center Zurich, Zurich, Switzerland., Silina K; Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland.; Comprehensive Cancer Center Zurich, Zurich, Switzerland., Sobottka B; Department of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland., Urdinez J; Department of Orthopaedics, Balgrist University Hospital, University of Zurich, Zurich, Switzerland.; Cutiss AG, Schlieren, Switzerland., Cecconi V; Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland.; Comprehensive Cancer Center Zurich, Zurich, Switzerland., Yagita H; Department of Immunology, Juntendo University School of Medicine, Tokyo, Japan., Movahedian Attar F; Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland.; Comprehensive Cancer Center Zurich, Zurich, Switzerland., Hiltbrunner S; Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland.; Comprehensive Cancer Center Zurich, Zurich, Switzerland.; Department of Hematology and Oncology, University Hospital Zurich, Zurich, Switzerland., Glarner I; Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland.; Comprehensive Cancer Center Zurich, Zurich, Switzerland., Moch H; Comprehensive Cancer Center Zurich, Zurich, Switzerland.; Department of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland., Tugues S; Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland.; Comprehensive Cancer Center Zurich, Zurich, Switzerland., Becher B; Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland.; Comprehensive Cancer Center Zurich, Zurich, Switzerland., van den Broek M; Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland. vandenbroek@immunology.uzh.ch.; Comprehensive Cancer Center Zurich, Zurich, Switzerland. vandenbroek@immunology.uzh.ch.

Publikováno v: Nature communications [Nat Commun] 2021 Feb 03; Vol. 12 (1), pp. 769. Date of Electronic Publication: 2021 Feb 03.